Fzata, Inc.

0 followers


Fzata’s capturing the “holy grail” of oral biologics with our transformational Bioengineered Probiotic Yeast Medicines (BioPYM) modality. With $17M in non-dilutive NIH funding, Fzata has developed a pipeline of drug candidates for gastrointestinal-related disorders. BioPYM platform uses live yeast a... Read more

Industries

Stage

Employees

Links

Org chart

Zhiyong Yang

Collapse
Elizabeth Anne Smith, PhD MBA
Chief Business Officer
Hanping Feng
Chief Scientific Officer